指南与共识消化内镜消化道肿瘤与早癌

内镜医师对1至4个非进展期腺瘤切除后监测间期的依从性

Endoscopist Adherence to Postpolypectomy Surveillance Interval Recommendations Following Removal of 1 to 4 Nonadvanced Adenomas.
指南 / 共识 · Clin Gastroenterol Hepatol · 2026-09-15

该横断面研究纳入2019至2024年Kaiser Permanente Northern California平均风险成人,评估内镜医师对2020年更新指南中1-2个非进展期腺瘤(NAA)推荐7-10年、3-4个NAA推荐3-5年监测间期的依从性。1-2个NAA的依从性从2021年68.1%升至2024年71.9%,3-4个NAA持续>90.0%;内镜医师多选择间期范围的上限或下限而非中间年份。

要点

  • 1-2个NAA的7-10年间期依从性从2021年68.1%改善至2024年71.9%。
  • 3-4个NAA的3-5年间期依从性持续大于90.0%。
  • 1-2个NAA组中45.9%-47.2%被赋予10年间期,提示过度监测风险较高。

核心结论

  • 2020年指南更新后,1-2个NAA的监测间期依从性有所改善但仍低于3-4个NAA组。
  • 1-2个NAA患者潜在过度监测的风险显著高于3-4个NAA患者。

研究设计与样本

  • 横断面研究,纳入2019至2024年在Kaiser Permanente Northern California接受结肠镜并切除1-4个NAA的平均风险成人。
  • 监测间期取自结肠镜操作记录表,每年计算指南依从比例及间期范围使用情况。

主要发现

  • 1-2个NAA的7-10年间期依从性从2021年68.1%升至2024年71.9%。
  • 3-4个NAA的3-5年间期依从性持续大于90.0%。
  • 两组内镜医师均主要选择间期范围的上限或下限而非中间年份。
  • 2021至2024年,1-2个NAA组中45.9%-47.2%被赋予10年间期。
  • 3-4个NAA组中37.6%-39.5%被赋予5年间期。

关键数值与推荐

  • 2020年更新指南推荐1-2个NAA监测间期为7-10年。
  • 2020年更新指南推荐3-4个NAA监测间期为3-5年。

临床怎么用

  • 消化内科智能体应提示内镜医师对1-2个NAA患者避免默认选择10年间期。
  • 对3-4个NAA患者可维持现有较高依从性,注意避免常规选择5年间期上限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Current postpolypectomy surveillance guidelines (updated in 2020) recommend a 7- to 10-year surveillance interval for patients with 1 to 2 nonadvanced adenomas (NAAs) and a 3- to 5-year interval for those with 3 to 4 NAAs; however, endoscopist adherence to guideline recommendations is unknown. Therefore, we evaluated endoscopist adherence to guideline recommendations and use of interval ranges in a large integrated health care system. METHODS: The cross-sectional study was conducted with average-risk adult Kaiser Permanente Northern California patients who underwent a colonoscopy with removal of 1 to 4 NAAs in 2019 to 2024. Surveillance intervals were obtained from colonoscopy procedure flowsheets. The proportion of colonoscopies with a guideline adherent surveillance interval and use of interval ranges were calculated annually. RESULTS: Endoscopist adherence to the 7- to 10-year interval for patients with 1 to 2 NAAs improved from 68.1% in 2021 to 71.9% in 2024. In contrast, adherence to the 3- to 5-year interval for patients with 3 to 4 NAAs was consistently greater than 90.0%. For both 1 to 2 and 3 to 4 NAAs groups, endoscopists predominantly assigned the upper or lower bound of the interval range rather than the middle years. In 2021 to 2024, a 10-year interval was assigned in 45.9%-47.2% of patients with 1 to 2 NAAs. A 5-year interval was assigned in 37.6%-39.5% of patients with 3 to 4 NAAs. CONCLUSIONS: Since the update to postpolypectomy surveillance guidelines in 2020, endoscopist adherence to recommended follow-up intervals for patients with 1 to 2 NAAs has improved. However, adherence to recommended follow-up intervals remains lower for patients with 1 to 2 NAAs compared with those with 3 to 4 NAAs. These disparate adherence rates suggest that the potential for oversurveillance is substantially higher for patients with 1 to 2 vs 3 to 4 NAAs.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Hendel JM, Jensen CD, Merchant SA, et al. Endoscopist Adherence to Postpolypectomy Surveillance Interval Recommendations Following Removal of 1 to 4 Nonadvanced Adenomas. Clin Gastroenterol Hepatol. 2026. PMID: 42744069. doi:10.1016/j.cgh.2026.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。